BioAge Labs, Inc.
BIOANASDAQHealthcare● Active
$15.83
+$0.32(+2.08%)
Market Cap$596106671
P/E Ratio—
52W High$24
52W Low$4.065
BioAge Labs, Inc. (BIOA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOA · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $8.99M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $8.99M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $73.97M | $59.04M | $33.89M | $30.52M |
| G&A Expenses | $27.81M | $19.16M | $14.51M | $9.45M |
| Total Operating Expenses | $101.78M | $78.19M | $48.40M | $39.97M |
| Operating Income | ($92.78M) | ($78.19M) | ($48.40M) | ($39.97M) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $13.09M | $9.63M | $2.43M | $0.47M |
| Interest Expense | $0.70M | $2.37M | $7.79M | $0.24M |
| Income Before Tax | ($80.61M) | ($71.11M) | ($63.85M) | ($39.72M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($80.61M) | ($71.11M) | ($63.85M) | ($39.72M) |
| Net Margin %(computed) | -896.11% | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-2.24 | $-1.98 | $-1.87 | $-1.16 |
| Wtd Avg Shares | 35.93M | 35.85M | 34.20M | 34.17M |
| EBITDA | ($79.69M) | ($68.58M) | ($55.90M) | ($39.35M) |
| EBITDA Margin %(computed) | -885.99% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more BioAge Labs, Inc. data
About BioAge Labs, Inc. (BIOA) Income Statement
BioAge Labs, Inc. (BIOA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BIOA reported revenue of $0.01B, gross profit of $0.01B (gross margin 100.00%), and net income of ($0.08B) — a net profit margin of -896.11%.
Frequently asked questions
BIOA · 4 questionsBioAge Labs, Inc. (BIOA) reported revenue of $0.01B for 2025, up —% year-over-year.
BIOA revenueBIOA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09